Dr. Andres Zirlinger MD

Recommended Articles

• These Conditions Can Cause Dyspnea

  OverviewDyspnea is the clinical term for shortness of breath or breathlessness experienced by both healthy individuals and patients with respiratory or cardiovascular diseases. It can also be a temporary condition that quickly resolves on its own or a symptom of a more serious health condition. A...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• COPD Pathophysiology - How Do You Develop COPD?

  Chronic Obstructive Pulmonary Disease (COPD) is a chronic, progressive disease of the airways leading to irreversible air flow limitation. COPD encompasses two types of obstructive airway diseases:1. Chronic bronchitis – An obstruction of the airways2. Emphysema – An enlargement of air spaces...

• Asthmatic Bronchitis: Symptoms, Causes, and Treatments

  IntroductionEvery time you inhale, air enters your nose and mouth, and then flows down the throat through the air passageways called as bronchial tubes. For the air to reach the lungs, these passageways need to be open. To transport the oxygen to the tissues of the body, oxygen is passed into the...

• Community-Acquired Pneumonia: Causes, Symptoms, and Management

  Community-acquired pneumonia (CAP) refers to pneumonia that develops in people with very less or no contact with any medical setting such as a hospital or clinic. Most of the time, the people who are infected with CAP are healthy individuals.Background of the DiseaseFour million cases...

• Groundbreaking Triple-Therapy Could Be on the Horizon for Cystic Fibrosis

  Researchers work around the clock and the world to find new discoveries in terms of cystic fibrosis treatment. Thanks to foundations, donations, and ongoing research, cystic fibrosis has made leaps and bounds as far as treatment is concerned. There is one pharmaceutical company at the forefront of...